EUPRAXIA PHARMACEUTICALS INC. (EPRX) Operating cash flow 2022–2025
EUPRAXIA PHARMACEUTICALS INC. (EPRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$28.6MFY2025 · since FY2022: -$14.4M → -$28.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$28.6M | +4.8% |
| FY2024 | -$30.0M | -44.6% |
| FY2023 | -$20.7M | -44.1% |
| FY2022 | -$14.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice